De B K, Sampson J S, Ades E W, Huebner R C, Jue D L, Johnson S E, Espina M, Stinson A R, Briles D E, Carlone G M
Division of Bacterial and Mycotic Diseases, and Biotechnology Core Facility Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Vaccine. 2000 Mar 6;18(17):1811-21. doi: 10.1016/s0264-410x(99)00481-8.
All Streptococcus pneumoniae isolates tested to date express a species-common lipoprotein designated as pneumococcal surface adhesin A (PsaA). This protein is cell-associated, hydrophobic, immunogenic, and genetically conserved. It is currently under investigation as a potential component in third-generation pneumococcal vaccine formulations. To overcome the problem of low-level expression of native hydrophobic PsaA in S. pneumoniae, and also of the recombinant PsaA (rPsaA) in Escherichia coli, we generated a stable E. coli construct expressing functional palmitoylated rPsaA ( approximately 10 mg/l of fermentation culture) using Borrelia burgdorferi outer surface protein A (OspA, a hydrophobic lipoprotein) signal peptide. By Western blot analysis, the chimeric rPsaA ( approximately 34 kDa) was detected in the cell lysate using anti-PsaA antibodies. It was partially purified by extracting the cell pellet with PBS/Triton X(R)-114 buffers, followed by anion exchange filter chromatography. A trypsin digestion profile of rPsaA closely resembled that of the native protein, as revealed by SDS-PAGE/silver staining. Lipidation of rPsaA was confirmed by labeling recombinant E. coli cells with [(3)H] palmitic acid and analyzing the labeled E. coli cells by Western blotting coupled with autoradiography. Further, analysis of purified rPsaA by mass spectrometry (MALDI-TOF) revealed a heterogenous spectrum with a major peak (M+H)(+1) of mass 33,384 Da (theoretical mass of palmitoylated rPsaA=33,361 Da). Purified rPsaA was immunogenic in CBA/NCAHN-XID female mice following intranasal immunization with or without adjuvant, as determined by measurement of anti-PsaA serum IgG levels. These anti-PsaA antibodies reacted with both native and rPsaA polypeptides. Our data strongly suggest that E. coli-expressed rPsaA is palmitoylated and closely resembles the native protein in structure and immunogenicity. It was also observed to elicit measurable protection against nasopharyngeal carriage with S. pneumoniae.
迄今为止,所有检测的肺炎链球菌分离株均表达一种名为肺炎球菌表面黏附素A(PsaA)的种属共同脂蛋白。该蛋白与细胞相关,具有疏水性、免疫原性且基因保守。目前它正作为第三代肺炎球菌疫苗制剂的潜在成分进行研究。为克服肺炎链球菌中天然疏水性PsaA以及大肠杆菌中重组PsaA(rPsaA)低水平表达的问题,我们构建了一个稳定的大肠杆菌构建体,利用伯氏疏螺旋体外膜蛋白A(OspA,一种疏水性脂蛋白)信号肽表达功能性棕榈酰化rPsaA(约10 mg/L发酵培养物)。通过蛋白质印迹分析,使用抗PsaA抗体在细胞裂解物中检测到嵌合rPsaA(约34 kDa)。通过用PBS/Triton X - 114缓冲液提取细胞沉淀,随后进行阴离子交换过滤层析对其进行部分纯化。如SDS - PAGE/银染所示,rPsaA的胰蛋白酶消化图谱与天然蛋白的图谱非常相似。通过用[³H]棕榈酸标记重组大肠杆菌细胞并结合放射自显影的蛋白质印迹分析来确认rPsaA的脂化。此外,通过质谱分析(MALDI - TOF)纯化的rPsaA显示出异质谱,主峰(M + H)⁺¹的质量为33,384 Da(棕榈酰化rPsaA的理论质量 = 33,361 Da)。通过测量抗PsaA血清IgG水平确定,纯化的rPsaA在有无佐剂的情况下经鼻内免疫CBA/NCAHN - XID雌性小鼠后具有免疫原性。这些抗PsaA抗体与天然和rPsaA多肽均发生反应。我们的数据强烈表明,大肠杆菌表达的rPsaA被棕榈酰化,在结构和免疫原性上与天然蛋白非常相似。还观察到它能引发针对肺炎链球菌鼻咽部定植的可测量的保护作用。